Evidence map›Paper›PMID 35413241›Full record

ArticleCell2022

Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity.

Lauren B Rodda, Peter A Morawski, Kurt B Pruner, Mitchell L Fahning, Christian A Howard, Nicholas Franko, Jennifer Logue, Julie Eggenberger, Caleb Stokes, Inah Golez and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 141 papers.

0numbers the graph read from it
0cells of the map it votes in
141citing papers in PubMed
21.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

141 citing papers in PubMed, 219 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The multilayered identity of B cell memory.Cellular & molecular immunology · 2026
    Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

81 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Lauren B RoddaDepartment of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA.
Peter A MorawskiCenter for Fundamental Immunology, Benaroya Research Institute, Seattle, WA 98101, USA.
Kurt B PrunerDepartment of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA.
Mitchell L FahningCenter for Fundamental Immunology, Benaroya Research Institute, Seattle, WA 98101, USA.
Christian A HowardDepartment of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA.
Nicholas FrankoDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA.
Jennifer LogueDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA.
Julie EggenbergerDepartment of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA.
Caleb StokesDepartment of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA.
Inah GolezDepartment of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA.
Malika HaleCenter for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA 98101, USA.
Michael GaleDepartment of Immunology, Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA 98109, USA.
Helen Y ChuDivision of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98109, USA.
Daniel J CampbellDepartment of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA; Center for Fundamental Immunology, Benaroya Research Institute, Seattle, WA 98101, USA.
Marion PepperDepartment of Immunology, University of Washington School of Medicine, Seattle, WA 98109, USA. Electronic address: mpepper@uw.edu.
University of Washington · USBenaroya Research InstituteCenter for Infectious Disease Research · US

Funding

VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
University of Washington Arboviral Research Network (UWARN)U01AI151698 · NIAID · UNIVERSITY OF WASHINGTON · PI Michael Gale, PETER MACGARR RABINOWITZ · 2020 to 2026
$13.3M
Regulation of the Innate Immune Response by the Epithelium in AsthmaU19AI125378 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI CAMPBELL, DANIEL J · 2016 to 2020
$9.2M
Inducing durable, protective immune memory against malariaU01AI142001 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI KAPPE, STEFAN HI, PEPPER, MARION · 2019 to 2023
$5.5M
The Development and Function of Plasmodium-specific memory B cellsR01AI118803 · NIAID · UNIVERSITY OF WASHINGTON · PI PEPPER, MARION · 2017 to 2021
$3.0M
Regulation of cutaneous immunity and tissue-repair by a specialized population of CD4+ T cellsR01AI127726 · NIAID · BENAROYA RESEARCH INST AT VIRGINIA MASON · PI CAMPBELL, DANIEL J, GRATZ, IRIS KARINA · 2017 to 2021
$2.8M
Basic Training at the Intersection of Innate and Adaptive Immunity in DiseaseT32AI106677 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL, GOVERMAN, JOAN M · 2013 to 2022
$2.1M
Host inflammatory response to SARS-CoV-2R21AI158788 · NIAID · UNIVERSITY OF WASHINGTON · PI GALE, MICHAEL · 2021 to 2022
$485k
Acquisition of BD FACSymphony A3 Lite Flow CytometerS10OD024979 · OD · UNIVERSITY OF WASHINGTON · PI BLACK, MICHELE C · 2020 to 2020
$344k
NIAID NIH HHS R01 AI118803NIAID NIH HHS R01 AI127726NIAID NIH HHS R21 AI158788NIAID NIH HHS T32 AI007140NIAID NIH HHS T32 AI106677NIAID NIH HHS U01 AI142001NIAID NIH HHS U01 AI151698NIAID NIH HHS U19 AI125378NIH HHS S10 OD024979
6 · The paper itself

Abstract

Immune memory is tailored by cues that lymphocytes perceive during priming. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic created a situation in which nascent memory could be tracked through additional antigen exposures. Both SARS-CoV-2 infection and vaccination induce multifaceted, functional immune memory, but together, they engender improved protection from disease, termed hybrid immunity. We therefore investigated how vaccine-induced memory is shaped by previous infection. We found that following vaccination, previously infected individuals generated more SARS-CoV-2 RBD-specific memory B cells and variant-neutralizing antibodies and a distinct population of IFN-γ and IL-10-expressing memory SARS-CoV-2 spike-specific CD4

Indexed as

COVID-19SARS-CoV-2Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesHumansImmunity, HumoralSpike Glycoprotein, CoronavirusT-LymphocytesAntibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesSpike Glycoprotein, Coronavirusspike protein, SARS-CoV-2adaptive immune responseCOVID-19humanhybrid Immunitymemory B cellmemory T cellSARS-CoV-2vaccine

Identifiers

PMID35413241
PMCPMC8926873
OpenAlexW4220998607

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.